Added to YB: 2026-06-26
Pitch date: 2026-06-24
LOVE.TO [neutral]
Cannara Biotech Inc.
Author Info
Aurelion Research is a research analyst with a passion for markets, specializing in high‑conviction ideas across shipping, offshore drilling, and thematic equity research. Sign up for the newsletter.
Company Info
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
Market Cap
CAD 158.1M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.04
P/E
14.72
EV/Sales
1.51
Sector
Personal Care Products
Category
turnaround
Cannara Biotech Inc (TSE: LOVE)
LOVE.TO (watchlist): Quality Canadian cannabis operator, prior holding exited on low liquidity, now eyeing re-entry. Operating at 50% capacity w/ infrastructure built—just needs to plant more. Industry shakeout left quality players. Mgmt: strongest position ever, opening rooms on strong demand. Stock down on tiny $50K/day liquidity (likely one fund selling). Expects H2 2026 earnings beat. Awaiting reversal of downward momentum before entering.
Read full article (1 min)